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We identifi ed 131 strains of Vibrio fl uvialis among 400 
nonagglutinating Vibrio spp. isolated from patients with 
diarrhea in Kolkata, India. For 43 patients, V. fl uvialis was 
the sole pathogen identifi ed. Most strains harbored genes 
encoding hemolysin and metalloprotease; this fi nding 
may contribute to understanding of the pathogenicity of V. 
fl uvialis.
Many members of the family Vibrionaceae cause diarrheal disease; among these, Vibrio cholerae O1/
O139 and V. parahaemolyticus are responsible for several 
epidemics and pandemics (1,2). In Indonesia, >20% of 
diarrheal infections are caused by pathogenic Vibrio spp. 
(3). Some of these Vibrio spp. can grow in thiosulfate–
citrate–bile salts–sucrose agar as yellow colonies and do 
not agglutinate with V. cholerae O1 antiserum. These 
species are broadly defi ned as nonagglutinating (NAG) 
vibrios.
The emerging etiologic agent V. fl uvialis has caused 
sporadic cases and outbreaks of diarrhea in several 
countries (4–6). Species-specifi c minimal biochemical 
tests, e.g., lysine decarboxylase, ornithine decarboxylase, 
arginine didydrolase, and L-arabinose, are used to identify 
V. fl uvialis; without these tests, it may be confused with 
NAG vibrios, V. cholerae, and even Aeromonas spp. In 
most resource-poor countries, these tests are not performed, 
which may lead to labeling of V. fl uvialis as a NAG vibrio. 
Although V. fl uvialis is known to cause diarrhea, the 
mechanisms involved in its pathogenicity are not well 
established. To evaluate the prevalence of V. fl uvialis in 
India and possible mischaracterization as an NAG vibrio, 
we examined cases in which isolates from hospitalized 
patients with diarrhea were identifi ed as NAG vibrios and 
characterized the strains using phenotypic and genetic 
methods.
The Study
We examined 400 isolates identifi ed as NAG vibrios 
that were collected during 2002–2009 from 11,904 stool 
specimens from patients with diarrhea admitted to the 
Infectious Diseases and Beliaghata General Hospital, 
Kolkata, India. Specimens were screened for common 
enteric pathogens, according to standard protocols (7). 
Oxidase, string test, and arginine dihydrolase–positive 
strains that did not agglutinate with V. cholerae O1 
polyvalent or O139 monovalent antiserum were further 
confi rmed as V. fl uvialis by using a multiplex PCR 
targeting the toxR gene of V. fl uvialis and the ompW 
gene of V. cholerae (8,9). Isolates were also subjected 
to PCRs targeting different virulence-associated genes 
encoding the repeat in toxin (rtxA, rtxC), heat-stable 
enterotoxin (stn), type 3 secretion system (vcsC2, vcsV2, 
vcsN2 and vspD), cholera toxin (ctxA), toxin co-regulated 
pilus (tcpA), thermostable direct-hemolysin (tdh), TDH-
related hemolysin (trh), V. fl uvialis hemolysin (VFH), and 
metalloproteases, according to published methods (10–12).
Expression of VFH was determined in vitro by using 
erythrocytes from rabbit and sheep. Cytotoxin assay 
was performed with HeLa and Chinese hamster ovary 
cell lines by using sterile culture fi lters of the V. fl uvialis 
strains that were isolated as a sole pathogen. Antimicrobial 
drug susceptibility testing was performed by using the 
disk diffusion method with commercially available disks 
(Becton Dickinson, Sparks Glencoe, MD, USA), according 
to Clinical and Laboratory Standards Institute criteria 
(13). Because these guidelines do not include interpretive 
criteria for V. fl uvialis, breakpoints for Enterobacteriaceae 
were adopted. Escherichia coli ATCC 25922 was used as a 
quality control strain.
Pulsed-fi eld gel electrophoresis was performed 
according to the PulseNet standardized protocol for 
V. cholerae (14). Gel Compare II software (Applied 
Maths NV, Sint-Martens-Latem, Belgium) was used 
for electrophoresis pattern comparison that runs on Dice 
similarity index and unweighted pairgroup with arithmetic 
mean method.
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Among the 400 isolates presumptively identifi ed NAG 
vibrios, multiplex PCR confi rmed 131 and 269 strains (each 
strain representing a case) as V. fl uvialis and V. cholerae, 
respectively. The overall prevalence rate of V. fl uvialis 
among 11,904 hospitalized patients with diarrhea was 
1.1%. Abrupt appearance of V. fl uvialis was identifi ed in 
2002, although the surveillance of diarrheal infection was 
initiated at the Infectious Diseases and Beliaghata General 
Hospital in 1996 (www.niced.org.in/annual_reports.
htm). The isolation rate of V. fl uvialis gradually increased 
from 0.7% in 2002 to 2.2% in 2009 (Table 1). Of the 131 
strains of V. fl uvialis, 43 (33%) were identifi ed as the sole 
pathogen; the remaining 88 (67%) were isolated as a co-
pathogen with either V. cholerae, V. parahaemolyticus, E. 
coli, Shigella spp., parasites, or enteric viruses (data not 
shown). Among the mixed infections, V. fl uvialis with V. 
cholerae was isolated most often (17%), followed by V. 
fl uvialis and V. parahaemolyticus (8%). The presence of 
Vibrio spp. as mixed pathogens indicates that these patients 
likely acquired the infection from contaminated water 
or food. We analyzed the date of admission and place 
from where the patients resided and found no evidence 
for clusters of infection or small outbreaks caused by V. 
fl uvialis.
V. fl uvialis infection was much more often detected 
in adults (73%) than in children <5 years of age (27%). 
Clinical symptoms of sole infection caused by V. fl uvialis 
were similar to that of cholera: watery diarrhea (86%), 
severe dehydration status (28%), and abdominal pain 
(12%) (Table 2). Several previous investigations have 
identifi ed cholera-like diarrheal outbreaks caused by V. 
fl uvialis (4,5).
All the V. fl uvialis strains were negative for the 
virulence genes commonly reported in V. cholerae and 
V. parahaemolyticus, but >90% were positive for genes 
encoding VFH and metalloproteases. More than 80% of 
the strains expressed hemolysin against rabbit and sheep 
red blood cells. Hemolysin is a widely distributed virulence 
factor in most pathogenic Vibrio spp. Metalloprotease 
produced by V. fl uvialis is related to hemagglutination 
proteases of V. vulnifi cus, which enhances permeability and 
hemorrhagic activities (12). These factors may increase the 
virulence of V. fl uvialis and contribute to diarrhea.
When the culture fi ltrates were tested, cytotoxic effect 
was readily noticed in the Chinese hamster ovary and HeLa 
cell lines, i.e., cytoplasmic vacuolation, cell rounding, and 
destruction of the monolayer. In most strains isolated as 
a sole pathogen, the cytotoxic endpoint titer was 2–256 
(online Technical Appendix Table 1, wwwnc.cdc.gov/
EID/pdfs/12-0520-Techapp.pdf). The cell vacuolation 
phenomenon has been reported as a virulence factor in 
several enteric pathogens (online Technical Appendix 
References). 
In this study, V. fl uvialis strains were highly resistant 
to ampicillin (92%), streptomycin (85%), furazolidone 
(85%), and sulfamethoxazole/trimethoprim (70%) (online 
Technical Appendix Table 2). About half the number of 
strains were resistant to ciprofl oxacin and 45% to nalidixic 
acid; the lower resistance rate for nalidixic acid compared 
with fl uoroquinolones is unexpected and warrants further 
investigation to confi rm the additional mechanisms. In 
a previous study, we found that some V. fl uvialis strains 
carried the plasmid-mediated quinolone resistance gene 
allele qnrA1 and a gene encoding the aminoglycoside 
acetyltransferase (aac(6′)-Ib-cr), which reduces ciprofl o-
xacin activity (15). Fluroquinolone resistance and 
intermediate susceptibility to erythromycin (92%) are the 
unique features of the V. fl uvialis isolated in this study; 
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Table 1. Prevalence of Vibrio fluvialis among patients with diarrhea, Kolkata, India, 2002–2009 
Year No. samples No. (%) V. fluvialis isolates 
No. (%) patients 
Sole infection Mixed infection 
2002 2,285 16 (0.7) 5 (0.2) 11 (0.5) 
2003 1,673 8 (0.5) 1 (0.1) 7 (0.4) 
2004 2,430 19 (0.8) 6 (0.2) 13 (0.5) 
2005 1,472 17 (1.1) 7 (0.5) 10 (0.7) 
2006 930 12 (1.3) 4 (0.4) 8 (0.9) 
2007 842 9 (1.1) 2 (0.2) 7 (0.8) 
2008 1,124 24 (2.1) 8 (0.7) 16 (1.4) 
2009 1,153 26 (2.2) 10 (0.9) 16 (1.4) 
Total 11,909 131 (1.1) 43 (0.4) 88 (0.7) 
Table 2. Clinical features of Vibrio fluvialis–infected patients with 
diarrhea, Kolkata, India, 2002–2009 
Clinical feature 
No. (%) patients 
Sole infection Mixed infection 
Type of diarrhea   
 Watery 36 (86) 72 (81) 
 Bloody mucus, loose 7 (16) 16 (19) 
Dehydration status   
 Severe 12 (28) 14 (16) 
 Some or rare 31 (72) 74 (84) 
Fever   
 Yes 4 (9) 9 (10) 
 No 39 (91) 79 (90) 
Abdominal pain   
 Yes 5 (12) 11 (12) 
 No 38 (88) 77 (88) 
Age   
 >5 y 30 (70) 66 (75) 
 <5 y 13 (30) 22 (25) 
Sex   
 M 23 (53) 58 (66) 
 F 20 (47) 30 (34) 
this trend was not recorded in other Vibrio spp., e.g., V. 
cholerae and V. parahaemolyticus.
Although the V. fl uvialis strains exhibited distinct 
NotI restriction profi les in the denrogroam analysis, at 
least 4 major clades were identifi ed (Figure). Clades A 
and B, with strains isolated during 2002–2007, exhibited 
less antimicrobial drug resistance than did clade C and D 
strains identifi ed during 2008–2009; multidrug-resistant 
strains, especially those resistant to fl uroquinolones, were 
identifi ed in higher numbers in clades C and D (Figure).
Conclusions
Our results demonstrate an emerging trend of 
prevalence of V. fl uvialis among patients with acute 
diarrhea patients in Kolkata. The expression of cytotoxic 
activity and hemolysin may contribute to understanding the 
pathogenicity of V. fl uvialis. Further epidemiologic studies 
are necessary to elucidate the public health importance of 
V. fl uvialis–mediated diarrhea.
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indicates degree of similarity.
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etymologia
Coxsackievirus
[kok-sak′e-vi′rəs]
Named for Coxsackie, the small town on the Hudson River where they were fi rst isolated, human coxsackievi-
ruses are nonenveloped, positive-sense, single-stranded RNA viruses in the family Picornaviridae, genus Entero-
virus. Th ey were fi rst described by Gilbert Dalldorf, who was investigating suspected poliomyelitis outbreaks in 
upstate New York in the summer of 1947. Coxsackieviruses are divided into 2 groups, A and B. In suckling mice, 
group A viruses cause generalized myositis and fl accid paralysis, and group B viruses cause focal myositis and 
spastic paralysis. With the discovery of coxsackieviruses, Dalldorf also helped popularize the suckling mouse as an 
inexpensive laboratory animal model.
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